Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  IL13Ralpha2-specific hinge-optimized 41BB-co-stimulatory CAR truncated CD19-expressing autologous T-lymphocytes
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Genetically Modified T-cells in Treating Patients with Recurrent or Refractory Malignant Glioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: 13384, NCI-2014-01488, 117388, 118810, NCT02208362
Start Over